Holbæk, Denmark – Pharmacosmos announces that the first patient has been enrolled in Phosphare; a set of three Phase III comparative clinical trials evaluating the incidence and extent of IV iron-induced hypophosphatemia between Monofer® (iron isomaltoside) and Injectafer® /Ferinject® (ferric carboxymaltose) in adults with iron deficiency anaemia
More
[wp_ad_camp_4]Dextran-supplier Pharmacosmos extends its quality dextran offerings with DEAE-Dextran, manufactured in the
Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company
Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases
More
Holbæk, Denmark – Pharmacosmos announces that the first patient has been enrolled in Phosphare; a set of three Phase III
More[wp_ad_camp_4]Dextran-supplier Pharmacosmos extends its quality dextran offerings with DEAE-Dextran, manufactured in the company’s FDA and EDQM-approved facility in Denmark. Holbæk,
More
